메뉴 건너뛰기




Volumn 12, Issue 7, 2015, Pages 694-703

Quantitative μPET imaging of cerebral glucose metabolism and amyloidosis in the TASTPM double transgenic mouse model of alzheimer’s disease

Author keywords

Alzheimer s disease; Animal models; Biomarker; Positron emission tomography; 18F AV45; 18F FDG

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; BIOLOGICAL MARKER; RADIOPHARMACEUTICAL AGENT;

EID: 84952654623     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666150710104713     Document Type: Conference Paper
Times cited : (16)

References (53)
  • 2
    • 72049130805 scopus 로고    scopus 로고
    • Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
    • [2] Jack J, Clifford R, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9(1): 119-28 (2010).
    • (2010) Lancet Neurol , vol.9 , Issue.1 , pp. 119-128
    • Jack, J.1    Clifford, R.2    Knopman, D.S.3    Jagust, W.J.4    Shaw, L.M.5    Aisen, P.S.6
  • 4
    • 79958792912 scopus 로고    scopus 로고
    • Clinical amyloid imaging in Alzheimer's disease
    • [4] Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol 10(7): 667-70 (2011).
    • (2011) Lancet Neurol , vol.10 , Issue.7 , pp. 667-670
    • Herholz, K.1    Ebmeier, K.2
  • 5
    • 17844364259 scopus 로고    scopus 로고
    • Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD
    • [5] Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nuc Med Mol Imag 32(4): 486-510 (2005).
    • (2005) Eur J Nuc Med Mol Imag , vol.32 , Issue.4 , pp. 486-510
    • Mosconi, L.1
  • 6
    • 10744232413 scopus 로고    scopus 로고
    • Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B
    • [6] Klunk WE, Engler H, Nordberg A, Wang Y, Blomquist G, Holt DP, et al. Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B. Ann Neurol 55(3): 306-19 (2004).
    • (2004) Ann Neurol , vol.55 , Issue.3 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3    Wang, Y.4    Blomquist, G.5    Holt, D.P.6
  • 7
    • 0038792263 scopus 로고    scopus 로고
    • Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
    • [7] Mathis CA, Wang Y, Holt DP, Huang G-F, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46(13): 2740-54 (2003).
    • (2003) J Med Chem , vol.46 , Issue.13 , pp. 2740-2754
    • Mathis, C.A.1    Wang, Y.2    Holt, D.P.3    Huang, G.-F.4    Debnath, M.L.5    Klunk, W.E.6
  • 8
    • 43849083580 scopus 로고    scopus 로고
    • Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
    • [8] Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131(6): 1630-45 (2008).
    • (2008) Brain , vol.131 , Issue.6 , pp. 1630-1645
    • Ikonomovic, M.D.1    Klunk, W.E.2    Abrahamson, E.E.3    Mathis, C.A.4    Price, J.C.5    Tsopelas, N.D.6
  • 9
    • 84863869296 scopus 로고    scopus 로고
    • Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloidbeta plaques: A prospective cohort study
    • [9] Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Colemant RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloidbeta plaques: a prospective cohort study. Lancet Neurol 11(8): 669-78 (2012).
    • (2012) Lancet Neurol , vol.11 , Issue.8 , pp. 669-678
    • Clark, C.M.1    Pontecorvo, M.J.2    Beach, T.G.3    Bedell, B.J.4    Colemant, R.E.5    Doraiswamy, P.M.6
  • 10
    • 0025753852 scopus 로고
    • The molecular pathology of Alzheimer’s
    • [10] Selkoe DJ. The molecular pathology of Alzheimer’s. Neuron 6(4): 487-98 (1991).
    • (1991) Neuron , vol.6 , Issue.4 , pp. 487-498
    • Selkoe, D.J.1
  • 11
    • 49349092320 scopus 로고    scopus 로고
    • PET imaging of amyloid deposition in patients with mild cognitive impairment
    • [11] Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29(10): 1456-65 (2008).
    • (2008) Neurobiol Aging , vol.29 , Issue.10 , pp. 1456-1465
    • Forsberg, A.1    Engler, H.2    Almkvist, O.3    Blomquist, G.4    Hagman, G.5    Wall, A.6
  • 14
    • 33749506795 scopus 로고    scopus 로고
    • Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
    • [14] Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129(11): 2856-66 (2006).
    • (2006) Brain , vol.129 , Issue.11 , pp. 2856-2866
    • Engler, H.1    Forsberg, A.2    Almkvist, O.3    Blomquist, G.4    Larsson, E.5    Savitcheva, I.6
  • 15
    • 0036743220 scopus 로고    scopus 로고
    • Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
    • [15] Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 17(1): 302-16 (2002).
    • (2002) Neuroimage , vol.17 , Issue.1 , pp. 302-316
    • Herholz, K.1    Salmon, E.2    Perani, D.3    Baron, J.C.4    Holthoff, V.5    Frolich, L.6
  • 16
    • 45749151056 scopus 로고    scopus 로고
    • Animal models of Alzheimer's disease and frontotemporal dementia
    • [16] Götz J, Ittner LM. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9(7): 532-44 (2008).
    • (2008) Nat Rev Neurosci , vol.9 , Issue.7 , pp. 532-544
    • Götz, J.1    Ittner, L.M.2
  • 17
    • 27944471285 scopus 로고    scopus 로고
    • Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain
    • [17] Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25(46): 10598-606 (2005).
    • (2005) J Neurosci , vol.25 , Issue.46 , pp. 10598-10606
    • Klunk, W.E.1    Lopresti, B.J.2    Ikonomovic, M.D.3    Lefterov, I.M.4    Koldamova, R.P.5    Abrahamson, E.E.6
  • 18
    • 24044535149 scopus 로고    scopus 로고
    • PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease
    • [18] Toyama H, Ye D, Ichise M, Liow J-S, Cai L, Jacobowitz D, et al. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease. Eur J Nuc Med Mol Imaging 32(5): 593-600 (2005).
    • (2005) Eur J Nuc Med Mol Imaging , vol.32 , Issue.5 , pp. 593-600
    • Toyama, H.1    Ye, D.2    Ichise, M.3    Liow, J.-S.4    Cai, L.5    Jacobowitz, D.6
  • 19
    • 35348821915 scopus 로고    scopus 로고
    • Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography
    • [19] Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci 27(41): 10957-68 (2007).
    • (2007) J Neurosci , vol.27 , Issue.41 , pp. 10957-10968
    • Maeda, J.1    Ji, B.2    Irie, T.3    Tomiyama, T.4    Maruyama, M.5    Okauchi, T.6
  • 20
    • 84857959777 scopus 로고    scopus 로고
    • Small-animal PET imaging of amyloid-beta plaques with [11C] PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease
    • [20] Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, et al. Small-animal PET imaging of amyloid-beta plaques with [11C] PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS ONE 7(3): e31310 (2012).
    • (2012) Plos ONE , vol.7 , Issue.3
    • Manook, A.1    Yousefi, B.H.2    Willuweit, A.3    Platzer, S.4    Reder, S.5    Voss, A.6
  • 22
    • 84879911625 scopus 로고    scopus 로고
    • Longitudinal Assessment of Cerebral beta-Amyloid Deposition in Mice Overexpressing Swedish Mutant beta-Amyloid Precursor Protein Using 18F-Florbetaben PET
    • [22] Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, et al. Longitudinal Assessment of Cerebral beta-Amyloid Deposition in Mice Overexpressing Swedish Mutant beta-Amyloid Precursor Protein Using 18F-Florbetaben PET. J Nucl Med 54(7): 1127-34 (2013).
    • (2013) J Nucl Med , vol.54 , Issue.7 , pp. 1127-1134
    • Rominger, A.1    Brendel, M.2    Burgold, S.3    Keppler, K.4    Baumann, K.5    Xiong, G.6
  • 23
    • 84881392145 scopus 로고    scopus 로고
    • Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease
    • [23] Snellman A, Lopez-Picon FR, Rokka J, Salmona M, Forloni G, Scheinin M, et al. Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease. J Nucl Med 54(8): 1434-41 (2013).
    • (2013) J Nucl Med , vol.54 , Issue.8 , pp. 1434-1441
    • Snellman, A.1    Lopez-Picon, F.R.2    Rokka, J.3    Salmona, M.4    Forloni, G.5    Scheinin, M.6
  • 24
    • 84925581714 scopus 로고    scopus 로고
    • Longitudinal PET-MRI reveals [beta]-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion
    • [24] Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C, et al. Longitudinal PET-MRI reveals [beta]-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nat Med 20(12): 1485-92 (2014).
    • (2014) Nat Med , vol.20 , Issue.12 , pp. 1485-1492
    • Maier, F.C.1    Wehrl, H.F.2    Schmid, A.M.3    Mannheim, J.G.4    Wiehr, S.5    Lerdkrai, C.6
  • 25
    • 84858332587 scopus 로고    scopus 로고
    • Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: Limitations as a translatable model of Alzheimer's disease
    • [25] Luo F, Rustay NR, Ebert U, Hradil VP, Cole TB, Llano DA, et al. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging 33(5): 933-44 (2012).
    • (2012) Neurobiol Aging , vol.33 , Issue.5 , pp. 933-944
    • Luo, F.1    Rustay, N.R.2    Ebert, U.3    Hradil, V.P.4    Cole, T.B.5    Llano, D.A.6
  • 26
    • 84863433664 scopus 로고    scopus 로고
    • . Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease
    • [26] Poisnel G, Hérard A-S, El Tannir, El Tayara N, Bourrin E, Volk A, Kober F, et al. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease. Neuorbiol Aging 33(9): 1995-2005 (2012).
    • (2012) Neuorbiol Aging , vol.33 , Issue.9 , pp. 1995-2005
    • Poisnel, G.1    Hérard, A.-S.2    El, T.3    El Tayara, N.4    Bourrin, E.5    Volk, A.6    Kober, F.7
  • 27
    • 84875821298 scopus 로고    scopus 로고
    • Jiménez X, et al
    • [27] Rojas S, Herance JR, Gispert JD, Abad S, Torrent É, Jiménez X, et al. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Neurobiol Aging 34(7): 1790-98 (2013).
    • (2013) Neurobiol Aging , vol.34 , Issue.7 , pp. 1790-1798
    • Rojas, S.1    Herance, J.R.2    Gispert, J.D.3    Abad, S.4    Torrent, É.5
  • 28
    • 67649410208 scopus 로고    scopus 로고
    • Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease
    • [28] Kuntner C, Kesner AL, Bauer M, Kremslehner R, Wanek T, Mandler M, et al. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease. Mol Imaging Biol 11(4): 236-40 (2009).
    • (2009) Mol Imaging Biol , vol.11 , Issue.4 , pp. 236-240
    • Kuntner, C.1    Kesner, A.L.2    Bauer, M.3    Kremslehner, R.4    Wanek, T.5    Mandler, M.6
  • 29
    • 84868131284 scopus 로고    scopus 로고
    • Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease
    • [29] Rapic S, Backes H, Viel T, Kummer MP, Monfared P, Neumaier B, et al. Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiol Aging 34(1): 351-54 (2012).
    • (2012) Neurobiol Aging , vol.34 , Issue.1 , pp. 351-354
    • Rapic, S.1    Backes, H.2    Viel, T.3    Kummer, M.P.4    Monfared, P.5    Neumaier, B.6
  • 31
    • 80855156783 scopus 로고    scopus 로고
    • Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1
    • [31] Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, et al. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS ONE 6(11): e27068 (2011).
    • (2011) Plos ONE , vol.6 , Issue.11
    • Platt, B.1    Drever, B.2    Koss, D.3    Stoppelkamp, S.4    Jyoti, A.5    Plano, A.6
  • 32
    • 3142668938 scopus 로고    scopus 로고
    • Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes
    • [32] Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, et al. Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 1017(1-2): 130-36 (2004).
    • (2004) Brain Res , vol.1017 , Issue.1-2 , pp. 130-136
    • Howlett, D.R.1    Richardson, J.C.2    Austin, A.3    Parsons, A.A.4    Bate, S.T.5    Davies, D.C.6
  • 33
    • 84952650721 scopus 로고    scopus 로고
    • Investigations of brain glucose utilization in three transgenic mouse strains that develop neuropathological features of Alzheimer's disease
    • [33] Kelley J, Wintmolders C, Bottelbergs A, Waldron A-M, Wyffels L, Czech C, et al. Investigations of brain glucose utilization in three transgenic mouse strains that develop neuropathological features of Alzheimer's disease. Alzheimer's Dement 9(4): P329 (2013).
    • (2013) Alzheimer's Dement , vol.9 , Issue.4
    • Kelley, J.1    Wintmolders, C.2    Bottelbergs, A.3    Waldron, A.-M.4    Wyffels, L.5    Czech, C.6
  • 34
    • 77956412778 scopus 로고    scopus 로고
    • GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain
    • [34] Yao C-H, Lin W-L, Weng C-C, Hsiao I-T, Ting Y-S, Yen T-C, et al. GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain. Appl Radiat Isotopes 68(12): 2293-97 (2009).
    • (2009) Appl Radiat Isotopes , vol.68 , Issue.12 , pp. 2293-2297
    • Yao, C.-H.1    Lin, W.-L.2    Weng, C.-C.3    Hsiao, I.-T.4    Ting, Y.-S.5    Yen, T.-C.6
  • 35
    • 79955782487 scopus 로고    scopus 로고
    • Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice
    • [35] Wong KP, Sha W, Zhang X, Huang SC. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J Nucl Med 52(5): 800-07 (2011).
    • (2011) J Nucl Med , vol.52 , Issue.5 , pp. 800-807
    • Wong, K.P.1    Sha, W.2    Zhang, X.3    Huang, S.C.4
  • 36
    • 64549141924 scopus 로고    scopus 로고
    • NEMA NU 2-2007 performance measurements of the Siemens Inveon ™ preclinical small animal PET system
    • [36] Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ. NEMA NU 2-2007 performance measurements of the Siemens Inveon ™ preclinical small animal PET system. Phys Med Biol 54(8): 2359-76 (2009).
    • (2009) Phys Med Biol , vol.54 , Issue.8 , pp. 2359-2376
    • Kemp, B.J.1    Hruska, C.B.2    McFarland, A.R.3    Lenox, M.W.4    Lowe, V.J.5
  • 37
    • 0028700063 scopus 로고
    • Accelerated image reconstruction using ordered subsets of projection data
    • [37] Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 13(4): 601-09 (1994).
    • (1994) IEEE Trans Med Imaging , vol.13 , Issue.4 , pp. 601-609
    • Hudson, H.M.1    Larkin, R.S.2
  • 39
    • 0034244929 scopus 로고    scopus 로고
    • New, faster, image-based scatter correction for 3D PET
    • [39] Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 47(4): 1587-94 (2000).
    • (2000) IEEE Trans Nucl Sci , vol.47 , Issue.4 , pp. 1587-1594
    • Watson, C.C.1
  • 40
    • 34548713439 scopus 로고    scopus 로고
    • A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator
    • [40] Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. NeuroImage 38(1): 34-42 (2007).
    • (2007) Neuroimage , vol.38 , Issue.1 , pp. 34-42
    • Mirrione, M.M.1    Schiffer, W.K.2    Fowler, J.S.3    Alexoff, D.L.4    Dewey, S.L.5    Tsirka, S.E.6
  • 41
    • 35748982126 scopus 로고    scopus 로고
    • Aß deposition and related pathology in an APPx PS1 transgenic mouse model of Alzheimer’s disease
    • [41] Howlett DR, Bowler K, Soden PE, Riddell D, Davis JB, Richardson JC, et al. Aß deposition and related pathology in an APPx PS1 transgenic mouse model of Alzheimer’s disease. Histol Histopathol 23(1): 67-76 (2008).
    • (2008) Histol Histopathol , vol.23 , Issue.1 , pp. 67-76
    • Howlett, D.R.1    Bowler, K.2    Soden, P.E.3    Riddell, D.4    Davis, J.B.5    Richardson, J.C.6
  • 42
    • 84941997343 scopus 로고    scopus 로고
    • Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis
    • [42] Waldron A-M, Verhaeghe J, wyffels L, Schmidt M, Langlois X, Van Der Linden A, et al. Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis. Mol Imaging Biol 1-9 (2015).
    • (2015) Mol Imaging Biol , pp. 1-9
    • Waldron, A.-M.1    Verhaeghe, J.2    Wyffels, L.3    Schmidt, M.4    Langlois, X.5    Van Der Linden, A.6
  • 43
    • 84923804486 scopus 로고    scopus 로고
    • Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
    • [43] Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus F-J, et al. Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models. PLoS ONE 10(2): e0116678 (2015).
    • (2015) Plos ONE , vol.10 , Issue.2
    • Brendel, M.1    Jaworska, A.2    Grießinger, E.3    Rötzer, C.4    Burgold, S.5    Gildehaus, F.-J.6
  • 44
    • 84885709706 scopus 로고    scopus 로고
    • Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET
    • [44] Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, et al. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. NeuroImage 84: 843-53 (2014).
    • (2014) Neuroimage , vol.84 , pp. 843-853
    • Brendel, M.1    Delker, A.2    Rötzer, C.3    Böning, G.4    Carlsen, J.5    Cyran, C.6
  • 45
    • 77955981090 scopus 로고    scopus 로고
    • Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
    • [45] Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347: 179-85 (2010).
    • (2010) Brain Res , vol.1347 , pp. 179-185
    • Nicholson, R.M.1    Kusne, Y.2    Nowak, L.A.3    Laferla, F.M.4    Reiman, E.M.5    Valla, J.6
  • 46
    • 0034616277 scopus 로고    scopus 로고
    • Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography
    • [46] Reiman EM, Uecker A, Gonzalez-Lima F, Minear D, Chen K, Callaway NL, et al. Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. NeuroReport 11(5): 987-91 (2000).
    • (2000) Neuroreport , vol.11 , Issue.5 , pp. 987-991
    • Reiman, E.M.1    Uecker, A.2    Gonzalez-Lima, F.3    Minear, D.4    Chen, K.5    Callaway, N.L.6
  • 47
    • 41649097332 scopus 로고    scopus 로고
    • FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice
    • [47] Valla J, Gonzalez-Lima F, Reiman EM. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int J Develop Neurosci 26(3-4): 253-58 (2008).
    • (2008) Int J Develop Neurosci , vol.26 , Issue.3-4 , pp. 253-258
    • Valla, J.1    Gonzalez-Lima, F.2    Reiman, E.M.3
  • 48
    • 33749256422 scopus 로고    scopus 로고
    • Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice
    • [48] Valla J, Schneider L, Reiman EM. Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice. Brain Res 1116(1): 194-200 (2006).
    • (2006) Brain Res , vol.1116 , Issue.1 , pp. 194-200
    • Valla, J.1    Schneider, L.2    Reiman, E.M.3
  • 49
    • 84891702999 scopus 로고    scopus 로고
    • Mapping changes in mouse brain metabolism with PET/CT
    • [49] Welch A, Mingarelli M, Riedel G, Platt B. Mapping changes in mouse brain metabolism with PET/CT. J Nucl Med 54(11): 1946-53 (2013).
    • (2013) J Nucl Med , vol.54 , Issue.11 , pp. 1946-1953
    • Welch, A.1    Mingarelli, M.2    Riedel, G.3    Platt, B.4
  • 50
    • 79957872121 scopus 로고    scopus 로고
    • Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease
    • [50] Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimer's Dis 24(3): 547-57 (2011).
    • (2011) J Alzheimer's Dis , vol.24 , Issue.3 , pp. 547-557
    • Scheff, S.W.1    Price, D.A.2    Schmitt, F.A.3    Scheff, M.A.4    Mufson, E.J.5
  • 51
    • 78650698306 scopus 로고    scopus 로고
    • Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
    • [51] Kadir A, Marutle A, Gonzalez D, Scholl M, Almkvist O, Mousavi M, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain 134(1): 301-17 (2010).
    • (2010) Brain , vol.134 , Issue.1 , pp. 301-317
    • Kadir, A.1    Marutle, A.2    Gonzalez, D.3    Scholl, M.4    Almkvist, O.5    Mousavi, M.6
  • 52
    • 84855369203 scopus 로고    scopus 로고
    • Evidence for astrocytosis in prodromal alzheimer disease provided by 11c-deuterium-l-deprenyl: A multitracer PET paradigm combining 11C-pittsburgh compound B and 18F-FDG
    • [52] Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for astrocytosis in prodromal alzheimer disease provided by 11c-deuterium-l-deprenyl: a multitracer PET paradigm combining 11C-pittsburgh compound B and 18F-FDG. J Nucl Med 53(1): 37-46 (2012).
    • (2012) J Nucl Med , vol.53 , Issue.1 , pp. 37-46
    • Carter, S.F.1    Scholl, M.2    Almkvist, O.3    Wall, A.4    Engler, H.5    Langstrom, B.6
  • 53
    • 84923558350 scopus 로고    scopus 로고
    • In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions
    • [53] Klupp E, Förster S, Grimmer T, Tahmassian M, Yakushev I, Sorg C, et al. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions. Brain Connect 4(5): 371-83 (2014).
    • (2014) Brain Connect , vol.4 , Issue.5 , pp. 371-383
    • Klupp, E.1    Förster, S.2    Grimmer, T.3    Tahmassian, M.4    Yakushev, I.5    Sorg, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.